Cell Tribune
CellTribune.com provides business and research news updates for the cell and gene therapy industry. CellTribune follows the companies and people who drive innovation in this exciting technology. The goal of CellTribune is to be recognized as the media leader and the go-to source for originally-reported, quality news coverage in this industry. We strive to become the link between budding companies, analysts and institutional investors. Submit your press release to Cell Tribune for immediate publication.
U.S. Food and Drug Administration Places Clinical Hold On Cellectis MELANI-01...
Cellectis a biopharmaceutical company focused on developing immunotherapies based on gene-edited allogeneic CAR T-cells (UCART), today announced that the MELANI-01 trial has been placed...
New Antimicrobial Resistance (AMR) Action Fund steps in to save collapsing...
Partnership aims to bring 2 to 4 new antibiotics to patients by the end of the decade and facilitate needed long-term policy solutions
Today, more...
Sonoma Biotherapeutics launches with $40 million in Series A funding to...
Company founded by four pioneers of Treg cell biology and cell therapy and financed by a syndicate of leading biotech investors
SOUTH SAN FRANCISCO, Calif....
Tmunity and Oncora Medical Partner to Advance the Use of Real-World...
Tmunity Therapeutics, Inc., a private clinical-stage biotherapeutics company focused on saving and improving lives by delivering the full potential of next-generation T-cell immunotherapy, today...
Sigilon Therapeutics approaches the clinic
Orphan status for its haemophilia cell therapy and buy-in from Lilly on its diabetes project are good signs for Sigilon, but research is still...
National Academy of Medicine Launches Global Competition Seeking Solutions for Improving...
The National Academy of Medicine (NAM), in collaboration with eight global organizations representing more than 40 countries and territories, announced today the launch of...
University of Minnesota opens first-ever US clinical trial of engineered iPSC-derived...
Third first-in-human cancer treatment trial to open at U of M in last two months
MINNEAPOLIS, MN- October 21, 2019 - A new...
MilliporeSigma Becomes the First to Use Acoustic Technology for Cell Therapy...
MilliporeSigma today announced it has acquired FloDesign Sonics, of Wilbraham, Massachusetts, developer of a unique acoustic cell processing platform
MilliporeSigma today announced it has...
ReNeuron Presents Positive Clinical Data at the American Academy of Ophthalmology...
Study investigator presents positive efficacy data in ongoing retinal disease clinical trial
ReNeuron Group plc (AIM: RENE), a global leader in the development...
Mogrify Raises Additional $16 Million to Advance its Mission to Transform...
Initial close of Series A funding brings the total raised to over $20 million to dateFunding will accelerate Mogrify’s internal cell therapy programs, and...
